Literature DB >> 34018151

Prevalence and Factors of Hypertension Among Bangladeshi Adults.

Moriam Khanam1, Emran Hasan2, Abdur Razzaque Sarker3.   

Abstract

INTRODUCTION: Hypertension is one of the leading causes of morbidity and mortality in developing countries, especially in South Asian countries including Bangladesh. AIM: This study aimed to assess the prevalence, risk factors, and inequality of hypertension in Bangladesh.
METHODS: This study analyzed the Bangladesh Demographic and Health Survey data from 2017-2018. A total of 12,863 people aged 18 years and above were included in this study. Both bivariate and multivariate analyses were performed to observe the effects of different factors and reported as adjusted ORs (AORs) with 95% CIs. Concentration index and concentration curve were used to measure the inequality in the distribution of hypertension among people with varying socio-economic status.
RESULTS: This study found that the prevalence of hypertension was 27.43% while this rate was 28.43% among females and 26.11% among males. The prevalence was the highest (49.26%) among those from the highest age group and among individuals who belonged to the richest households (p < 0.001). The concentration index for hypertension was 0.07. Our study suggests that the risk of having hypertension was higher among respondents who were female, elderly, were overweight or obese; had diabetes; or were from Barisal and Rangpur divisions.
CONCLUSION: Our study showed that more than one quarter of respondents had hypertension. Early diagnosis and proper management of the risk factors for hypertension are crucial to halt this emerging public health problem. A joint effort involving public, private, and non-governmental organizations is necessary to tackle the burden of hypertension faced by Bangladesh and similar developing countries in South Asia.

Entities:  

Keywords:  Bangladesh; Hypertension; Inequality; Risk factor; South Asia

Year:  2021        PMID: 34018151     DOI: 10.1007/s40292-021-00461-x

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  10 in total

1.  Regional differences in the prevalence of arterial hypertension in Croatia.

Authors:  Marijan Erceg; Josipa Kern; Andrea Babić-Erceg; Ana Ivicević-Uhernik; Silvije Vuletić
Journal:  Coll Antropol       Date:  2009-04

2.  Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study.

Authors:  Deborah A Levine; Cora E Lewis; O Dale Williams; Monika M Safford; Kiang Liu; David A Calhoun; Yongin Kim; David R Jacobs; Catarina I Kiefe
Journal:  Hypertension       Date:  2010-12-06       Impact factor: 10.190

3.  Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study.

Authors:  Uchechukwu K A Sampson; Todd L Edwards; Eiman Jahangir; Heather Munro; Minaba Wariboko; Mariam G Wassef; Sergio Fazio; George A Mensah; Edmond K Kabagambe; William J Blot; Loren Lipworth
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-12-23

4.  Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Authors:  Miyuki Tsuchihashi-Makaya; Sanae Hamaguchi; Shintaro Kinugawa; Takashi Yokota; Daisuke Goto; Hisashi Yokoshiki; Norihiro Kato; Akira Takeshita; Hiroyuki Tsutsui
Journal:  Circ J       Date:  2009-07-31       Impact factor: 2.993

5.  Prevalence and Determinants of Comorbid Diabetes and Hypertension in Nepal: Evidence from Non Communicable Disease Risk Factors STEPS Survey Nepal 2013.

Authors:  A R Pandey; K B Karki; S Mehata; K K Aryal; P Thapa; A Pandit; B Bista; P Dhakal; M Dhimal
Journal:  J Nepal Health Res Counc       Date:  2015 Jan-Apr

6.  Levels and correlates of nutritional status of women of childbearing age in rural Bangladesh.

Authors:  Rasheda Khanam; Anne Shee Cc Lee; Malathi Ram; M A Quaiyum; Nazma Begum; Allysha Choudhury; Parul Christian; Luke C Mullany; Abdullah H Baqui
Journal:  Public Health Nutr       Date:  2018-08-15       Impact factor: 4.022

7.  Sex-specific prevalence, inequality and associated predictors of hypertension, diabetes, and comorbidity among Bangladeshi adults: results from a nationwide cross-sectional demographic and health survey.

Authors:  Nausad Ali; Raisul Akram; Nurnabi Sheikh; Abdur Razzaque Sarker; Marufa Sultana
Journal:  BMJ Open       Date:  2019-09-17       Impact factor: 2.692

8.  Hypertension prevalence and its trend in Bangladesh: evidence from a systematic review and meta-analysis.

Authors:  Mohammad Ziaul Islam Chowdhury; Meshbahur Rahman; Tanjila Akter; Tania Akhter; Arifa Ahmed; Minhajul Arifin Shovon; Zaki Farhana; Nashit Chowdhury; Tanvir C Turin
Journal:  Clin Hypertens       Date:  2020-06-01

9.  Association between body mass index (BMI) and hypertension in south Asian population: evidence from nationally-representative surveys.

Authors:  Fariha Binte Hossain; Md Shajedur Rahman Shawon; Gourab Adhikary; Ariful Bari Chowdhury
Journal:  Clin Hypertens       Date:  2019-12-15

10.  Risk factors for non-communicable diseases in Bangladesh: findings of the population-based cross-sectional national survey 2018.

Authors:  Baizid Khoorshid Riaz; Md Ziaul Islam; A N M Shamsul Islam; M M Zaman; Md Akram Hossain; Md Mujibur Rahman; Fahmida Khanam; K M Bayzid Amin; Irfan Nowroze Noor
Journal:  BMJ Open       Date:  2020-11-27       Impact factor: 2.692

  10 in total
  2 in total

1.  Inequalities in Undiagnosed Hypertension Among Adult Population in Bangladesh: Evidence from a Nationally Representative Survey.

Authors:  Mohammad Rifat Haider; Rajat Das Gupta
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-11-10

2.  Underweight, overweight or obesity, diabetes, and hypertension in Bangladesh, 2004 to 2018.

Authors:  Phuong Hong Nguyen; Salauddin Tauseef; Long Quynh Khuong; Rajat Das Gupta; Sk Masum Billah; Purnima Menon; Samuel Scott
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.